Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113831360A reveals a novel amide-directed borylation route for 1-carbazole-boronic acid pinacol ester, offering significant cost reduction and simplified purification for OLED and pharma manufacturing.
Patent CN105130744A details high-yield synthesis. Offers supply chain stability and cost reduction for pharmaceutical intermediate manufacturing globally.
Patent CN104945316B enables green microwave synthesis. High yield, low waste. Reliable supply chain for pharmaceutical intermediates.
Patent CN103570617B reveals high-purity oxidation method. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical intermediates.
Patent CN111662260B reveals a 7-step synthesis of saffloneoside. Offers stable intermediates and scalable routes for cerebral ischemia drug development.
Patent CN104086488A reveals efficient pyrimidine synthesis enabling cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN103073555B reveals high-yield synthesis route. Offers cost reduction in pharma manufacturing and reliable pharmaceutical intermediate supplier capabilities for global supply chains.
Advanced process for cephalosporin derivatives using selective activated carbon adsorption. Enhances Z-isomer purity and reduces phenylacetic acid impurities for pharmaceutical manufacturing.
Patent CN104830744A details a novel SD-AS coupled enzyme method for (R)-phenylglycol. Achieves 100% e.e. and 99.9% yield, offering significant cost reduction and supply reliability for pharmaceutical manufacturing.
Novel low-temperature esterification process for estradiol derivatives. Enhances yield and purity while reducing toxic reagent usage for global supply chains.
Patent CN105481925A reveals a novel catalytic transfer hydrogenation route for high-purity Obeticholic Acid intermediates, ensuring supply chain reliability.
Patent CN109021147B reveals a novel organic acid-base purification method for Sugammadex Sodium, eliminating dialysis and ensuring >99.5% purity with controlled oxidation impurities.
Patent CN112941114A reveals high-purity enzymatic route for chiral triols. Reduces production cost and improves supply chain reliability for global pharmaceutical intermediates manufacturing.
Patent CN116751242A reveals mild esterification for estradiol derivatives ensuring high purity and green chemistry compliance for reliable pharmaceutical intermediates supply chains globally.
Patent CN115057840B details a visible light-promoted synthesis of 3-acyl coumarins. This method offers cost reduction in fine chemical manufacturing and high-purity intermediates.
Patent CN114381441B reveals imine reductase catalysis for optical pure chiral amino alcohols. Offers mild conditions and high stereoselectivity for pharmaceutical supply chains.
Patent CN1978442A details a novel mannitol-based route for Nepyrrolol HCl, offering improved purity and scalability for reliable pharmaceutical intermediate suppliers.
Patent CN115948356B reveals high-efficiency carbonyl reductase mutants for lipoic acid intermediates, offering supply chain stability and cost reduction.
Patent CN111606811B reveals a solvent-free, high-yield route for terbinafine hydrochloride. Discover cost-effective manufacturing and reliable supply chain solutions.
Novel selenium-bridged ruthenium carborane synthesis patent CN103739627B offers high purity and scalable routes for boron-rich pharmaceutical intermediates ensuring supply chain stability.